{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:22:01Z","timestamp":1785252121511,"version":"3.55.0"},"reference-count":79,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T00:00:00Z","timestamp":1149638400000},"content-version":"vor","delay-in-days":1284,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Drug Reviews"],"published-print":{"date-parts":[[2002,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Dihydroetorphine (DHE) is one of the strongest analgesic opioid alkaloids known; it is 1000 to 12,000 times more potent than morphine. Several<jats:italic>in vitro<\/jats:italic>and<jats:italic>in vivo<\/jats:italic>studies have shown that DHE is a selective \u03bc\u2010opioid receptor (OP<jats:sub>3<\/jats:sub>) agonist that also binds and activates all human recombinant \u03bc\u2010, \u03b4\u2010, and k\u2010opioid receptors (OP<jats:sub>3<\/jats:sub>, OP<jats:sub>1<\/jats:sub>, and OP<jats:sub>2<\/jats:sub>). The onset of the analgesic effect of DHE in rodents is rapid, 5 to 15 min after parenteral administration; the duration of action is short, the analgesic effect disappears within 120 min after administration. By oral administration much higher doses of DHE are required to produce analgesic effects. These characteristics are accounted for by the pharmacokinetic properties of DHE in the rat, namely, by rapid distribution of DHE from the injection site to the brain and rapid metabolism by glucuronidation in the gut and liver followed by elimination into the bile. Continuous infusion and repeated administration of DHE lead to the development of tolerance to analgesia, physical dependence, and a rewarding effect in normal rats but not in animals with formalin\u2010induced inflammation. Although formalin\u2010induced inflammation is only one type of pain stimulus, these findings suggest that DHE addiction would be observed only in the case of pain\u2010free conditions. Clinical reports in China show that sublingual doses of DHE, 20 to 180 \u03bcg, produce a potent analgesic effect with only mild side effects, including dizziness, somnolence, nausea, vomiting, constipation, and shortness of breath. To improve the short\u2010lasting effect following sublingual administration, transdermal delivery of DHE via a patch has been investigated. The patch formulation of DHE produces continuous analgesic effect with minimal physical dependence and rewarding effect in rats suffering from chronic pain. This patch formulation, which is very suitable for DHE, may be viable for the treatment of severe pain and is likely to improve patients' quality of life.<\/jats:p>","DOI":"10.1111\/j.1527-3458.2002.tb00236.x","type":"journal-article","created":{"date-parts":[[2010,8,13]],"date-time":"2010-08-13T20:39:40Z","timestamp":1281731980000},"page":"391-404","source":"Crossref","is-referenced-by-count":17,"title":["Dihydroetorphine: A Potent Analgesic: Pharmacology, Toxicology, Pharmacokinetics, and Clinical Effects"],"prefix":"10.1111","volume":"8","author":[{"given":"Satoshi","family":"Ohmori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,6,7]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)81924-3"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00758-X"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(90)90096-A"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(97)00112-9"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja00989a032"},{"key":"e_1_2_1_7_2","first-page":"21","article-title":"A survey of 185 dihydroetorphine hydrochloride abusers","volume":"4","author":"Cao YX","year":"1995","journal-title":"Chin Bull Drug Depend"},{"key":"e_1_2_1_8_2","first-page":"770","article-title":"Studies on transdermal delivery system of dihydroetorphine hydrochloride","volume":"31","author":"Chen XP","year":"1996","journal-title":"Acta Pharmacol Sinica"},{"key":"e_1_2_1_9_2","first-page":"91","article-title":"Decrease of cAMP and increase of amino acids contents in mouse brain after dihydroetorphine tolerance","volume":"19","author":"Chen MH","year":"1998","journal-title":"Acta Pharmacol Sinica"},{"key":"e_1_2_1_10_2","first-page":"16","article-title":"A survey on and analysis of dihydroetorphine utilization","volume":"4","author":"Chen YN","year":"1995","journal-title":"Chin Bull Drug Depend"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-200006000-00008"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199505000-00018"},{"key":"e_1_2_1_13_2","first-page":"697","volume-title":"Handbook of experimental pharmacology. Vol. 104\/11. Opioids II","author":"Foley KM.","year":"1993"},{"key":"e_1_2_1_14_2","first-page":"349","article-title":"Effect of vehicle pH, drug concentration and azone on the snake skin permeation of dihydroetorphine hydrochloride","volume":"32","author":"Guo QD","year":"1997","journal-title":"Chin Pharm J"},{"key":"e_1_2_1_15_2","first-page":"9","article-title":"Analgesic and other central nervous system depressive effects of dihydroetorphine","volume":"3","author":"Huang M","year":"1982","journal-title":"Acta Pharmacol Sinica"},{"key":"e_1_2_1_16_2","first-page":"81","article-title":"Physical dependence of dihydroetorphine in mice and monkeys","volume":"3","author":"Huang M","year":"1982","journal-title":"Acta Pharmacol Sinica"},{"key":"e_1_2_1_17_2","first-page":"308","article-title":"Pharmacodynamics and pharmacokinetics of dihydroetorphine hydrochloride administered sublingually in mice and rats","volume":"9","author":"Huang M","year":"1988","journal-title":"Acta Pharmacol Sinica"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1975173267"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90347-6"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(96)12942-6"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(95)00013-B"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0922-4106(95)90078-0"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.53.3.377"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00460-4"},{"key":"e_1_2_1_25_2","first-page":"122","article-title":"Using dihydroetorphine to control cancer pain","volume":"5","author":"Li YS","year":"1996","journal-title":"Chin J New Drug"},{"key":"e_1_2_1_26_2","first-page":"223","article-title":"An epidemiological study on dihydroetorphine abuse","volume":"4","author":"Liu ZM","year":"1995","journal-title":"Chin Bull Drug Depend"},{"key":"e_1_2_1_27_2","first-page":"500","article-title":"Effects of low\u2010pH treatment on cAMP second messenger system regulated by different opioid agonists","volume":"20","author":"Liu JG","year":"1999","journal-title":"Acta Pharmacol Sinica"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(96)00044-8"},{"key":"e_1_2_1_29_2","first-page":"381","article-title":"Dihydroetorphine\u2010induced place preference was mediated by dopamine D1 receptors in rats","volume":"20","author":"Liu ZH","year":"1999","journal-title":"Acta Pharmacol Sinica"},{"key":"e_1_2_1_30_2","first-page":"27","article-title":"Dihydroetorphine reinforcement studied by conditioned place preference in rats","volume":"8","author":"Liu ZH","year":"1999","journal-title":"Chin J Drug Depend"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(95)00024-D"},{"key":"e_1_2_1_32_2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(25)38224-8","article-title":"Morphine\u2010induced alterations of immune status: Dose\u2010dependency, compartment specificity and antagonism by naltrexone","volume":"265","author":"Lysle DT","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00531-7"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)00074-5"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(98)00146-8"},{"key":"e_1_2_1_36_2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0022-3565(25)12190-3","article-title":"Regulation of opioid antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats","volume":"275","author":"Nichols ML","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)00156-Z"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01098-6"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)00129-8"},{"key":"e_1_2_1_40_2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0022-3565(24)38775-0","article-title":"Pharmacokinetic and pharmacodynamic evaluations of a potent analgesic dihydroetorphine in hairless rats","volume":"296","author":"Ohmori S","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1211\/0022357001777649"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.24.78"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198001103020221"},{"key":"e_1_2_1_44_2","first-page":"119","article-title":"Reserch advances of dihydroetorphine: From analgesia to detoxification","volume":"2","author":"Qin BY.","year":"1993","journal-title":"New Drugs Clin Rem"},{"key":"e_1_2_1_45_2","first-page":"521","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Reisin T","year":"1996"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)91028-6"},{"key":"e_1_2_1_47_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-3565(25)38109-7","article-title":"Examination of the neurochemical substrates mediating the motivational effects of opioids: Role of the mesolimbic dopamine system and D\u20101 vs D\u20102 dopamine receptors","volume":"265","author":"Shippenberg TS","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199504003-00005"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016079513007"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1089\/sct.1989.5.119"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(99)00036-3"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(96)00498-5"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(98)00537-2"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.17.1056"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.19.477"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.16.774"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(98)00060-4"},{"key":"e_1_2_1_58_1","unstructured":".UN document. Commission on Narcotic Drugs Report on the forty\u2010second session.1999; E\/CN.7\/1999\/15\/Rev. 1."},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(93)90292-S"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(93)90332-H"},{"key":"e_1_2_1_61_2","first-page":"210","article-title":"An investigation on the situation of utilization of narcotic medications for cancer pain patients","volume":"8","author":"Wang CY","year":"1999","journal-title":"Chin J Drug Depend"},{"key":"e_1_2_1_62_2","first-page":"36","article-title":"Experimental treatment of dihydroetorphine and naloxone on morphine\u2010dependent rats and monkeys","volume":"6","author":"Wang DX","year":"1992","journal-title":"Chin J Pharmacol Toxicol"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1995.tb05857.x"},{"key":"e_1_2_1_64_2","first-page":"281","article-title":"Binding of [3H]dihydroetorphine to opioid receptors in rat brain membrane","volume":"17","author":"Wang DX","year":"1996","journal-title":"Acta Pharmacol Sinica"},{"key":"e_1_2_1_65_2","first-page":"247","article-title":"Effect of dihydroetorphine treatment on regulation of \u03bc\u2010opioid receptor mRNA level in rat brain regions","volume":"11","author":"Wang DX","year":"1996","journal-title":"Chin J Pharmacol Toxicol"},{"key":"e_1_2_1_66_2","first-page":"8","article-title":"Psychological dependence potential of dihydroetorphine in rhesus monkey","volume":"6","author":"Wang WP","year":"1997","journal-title":"Chin Bull Drug Depend"},{"key":"e_1_2_1_67_2","first-page":"106","article-title":"Clinical investigation on detoxification of heroin addiction with dihydroetorphine hydrochloride","volume":"8","author":"Wang SF","year":"1992","journal-title":"Chin J Clin Pharmacol"},{"key":"e_1_2_1_68_2","first-page":"299","article-title":"Effect of dihydroetorphine hydrochrolide on mice parturition","volume":"31","author":"Wang AP","year":"1996","journal-title":"Chin J Obstet Gynecol"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2749256"},{"key":"e_1_2_1_70_1","volume-title":"Thirty\u2010first Report. WHO Technical Report Series 887","author":"WHO Expert Committee on Drug Dependence","year":"1999"},{"key":"e_1_2_1_71_2","first-page":"64","article-title":"Dihydroetorphine hydrochloride for moderate and severe cancer pain","volume":"13","author":"Wu GQ","year":"1991","journal-title":"Chin J Oncol"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00915-7"},{"key":"e_1_2_1_73_2","first-page":"387","article-title":"Immunosuppresive effects of intravenous self administration of dihydroetorphine on lymphocyte functions in rats","volume":"19","author":"Wu WR","year":"1998","journal-title":"Acta Pharmacol Sinica"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00369-0"},{"key":"e_1_2_1_75_2","first-page":"145","article-title":"The effect of dihydroetorphine on neurobehavioral teratology in offsprings of mice","volume":"5","author":"Yin H","year":"1996","journal-title":"Chin Bull Drug Depend"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.46.28869"},{"key":"e_1_2_1_77_2","first-page":"46","article-title":"Metabolism of [3H]\u2010dihydroetorphine in mice","volume":"11","author":"Yuan SL","year":"1987","journal-title":"Acad Military Med Sci"},{"key":"e_1_2_1_78_2","first-page":"61","article-title":"Distribution of [3H]\u2010dihydroetorphine in rat brain observed by in vitro quantitative autoradiography","volume":"9","author":"Yuan BL","year":"1995","journal-title":"Chin J Pharmacol Toxicol"},{"key":"e_1_2_1_79_2","first-page":"204","article-title":"A survey on the utilization of narcotic analgesic drugs in general hospitals of Qingdao","volume":"8","author":"Zang DL.","year":"1999","journal-title":"Chin J Drug Depend"},{"key":"e_1_2_1_80_2","first-page":"218","article-title":"Physical dependence of dihydroetorphine produced by continuous intraveous infusion in rats","volume":"3","author":"Zhang YG","year":"1994","journal-title":"Chin Bull Drug Depend"}],"container-title":["CNS Drug Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1527-3458.2002.tb00236.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1527-3458.2002.tb00236.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T12:33:42Z","timestamp":1740400422000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1527-3458.2002.tb00236.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["10.1111\/j.1527-3458.2002.tb00236.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1527-3458.2002.tb00236.x","archive":["Portico"],"relation":{},"ISSN":["1080-563X","1527-3458"],"issn-type":[{"value":"1080-563X","type":"print"},{"value":"1527-3458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}